Carlos Bazan MD (He/Him)

Clinical Pharmacology

Director, Medical Innovation / Viatris Medical Affairs Phase-3: SOS-AMI (selatogrel IND for AMI) Phase-3: OPUS 1,2 (cenerimod IND for SLE/Lupus)

Join to view full profile

1000 Alafaya Trail(East Orlando)Oviedo, FL 32765
Phone+1 516-589-2189

Dr. Bazan is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Bazan's full profile Already have an account?

Summary

Carlos Bazan MD, is a Viatris Global Medical Affairs professional based in Florida.
As Director MSL for the Viatris Medical Innovation Team, Dr. Bazan is in charge of the Southeast US territories, for two [phase-3] global clinical trials: the "SOS-AMI", selatogrel IND: Acute Myocardial Infarction), and the "OPUS", cenerimod IND: Systemic Lupus Erythematosus/SLE). Both, RCTs (randomized placebo-controlled clinical trials) are open. Sites are still screening and enrolling potential study participants.
Southeast US (in this case) has: KY, NC, SC, TN, AL, GA, FL and PR.
For more information, for Investigators/HCPs, please contact Viatris Medical Affairs, via their corporate website www.viatris.com

Education & Training

Universidad Autonoma de GuadalajaraClass of 1997

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Awards, Honors, & Recognition

Harvard Medical School Postgraduate Association HMS Postgraduate Association, 2004

Clinical Trials

A Study to Evaluate Effectiveness of Imiquimod 5% Cream in Superficial Basal Cell Carcinoma
COMPLETED
PHASE3
Treatment of Nodular Basal Cell Carcinoma (BCC) With Imiquimod 5% Cream After Curettage
COMPLETED
PHASE4
Basal Cell Carcinoma Recurrence After Mohs Surgery
COMPLETED

Committees

Co-Inventor, Hands-on Course Instructor (Hilton Head), Aptos Threads Scaffolding Minimally Invasive Face Lift 2006 - 2006

Research History

US Innovation Team“SOS-AMI”, Phase-3, RCT, P2Y12 Selatogrel (IND), fast-acting, short half life, reversible, SQ for STEMI (AMI, OMI), to be self-administered by patient via self-injector, at onset of AMI symptoms, before activating EMS.2024 - 2026
Country Manager (Spain)Ticagrelor (Bayer) -Galileo Study -Mount Sinai (New York City-Icahn)
Sr. Clinical Research AssociateBenralizumab (GSK) -Sirocco Study -Calima Study -Bora Study

Professional Memberships

American Thoracic Society - ATS
Member
American College of Chest Physicians - ACCP
Member
American Heart Association - AHA
Member
American College of Cardiology (ACC)
Member
American Society for Law, Medicine and Ethics (ASLME)
Member

Other Languages

Spanish, Portuguese

Industry Relationships

Director Medical Innovation, Viatris | US Medical Affairs2018 - Present
Director Global Medical Affairs, Mylan L. P.MSL Respiratory and Allergy2018 - Present